Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Editas Medicine, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 314 | 316 | +2 |
| Shares | 53.2M | 52.2M | −1.01M (−1.9%) |
| Value | $2.23B | $2.96B | +$728.6M (+32.6%) |
New holders (45)
Institutions that held Editas Medicine, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (43)
Institutions that held Editas Medicine, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.